Immix Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -130 | -90 | ||
EBITDA | -11,542 | -10,673 | -10,585 | -7,480 |
EBIT | -10,803 | -10,676 | -7,577 | |
Net Income | -11,557 | -10,086 | -10,687 | -7,585 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,756 | -9,859 | -11,194 | -6,278 |
Cash | 225,491 | 79,250 | 93,928 | 15,947 |
Basic Shares | 63,771 | 55,369 | 38,286 | 31,926 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-89,517 |
Gross Profit | -364 | -115 | -5 | -89,519 |
EBITDA | -29,591 | -21,541 | -15,563 | -8,216 |
EBIT | -29,956 | -21,657 | -15,569 | -8,218 |
Net Income | -29,438 | -21,613 | -15,426 | -8,229 |
Net Change In Cash | 0 | 0 | 0 | -89,517 |
Free Cash Flow | -24,663 | -15,772 | -11,423 | -7,408 |
Cash | 93,928 | 17,681 | 17,509 | 13,436 |
Basic Shares | 32,965 | 28,285 | 17,341 | 13,887 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.18 |
2026-03-31 | -$0.18 |
2025-12-31 | -$0.28 |
2025-09-30 | -$0.24 |